Feasibility of High-intensity Functional Exercise with Simultaneous Cognitive Challenge for Older People with Falls Risk

February 21, 2025 updated by: Annika Toots, Umeå University

The Feasibility of a High-intensity Functional Exercise Program with Simultaneous Cognitive Challenge to Improve Physical and Cognitive Function in Older People with Intermediate Risk for Falls: a Randomized Controlled Pilot Trial

This study aims to evaluate the feasibility of a high-intensity functional exercise program with simultaneous cognitive challenge (HIFE+cog) among older people at risk of falls. The evaluation design and intervention development will be assessed with the following specific aims:

  1. To investigate the acceptability and safety of the HIFE+cog program in older people at risk of falls, and the methods used in the study by evaluating recruitment, compliance with the intervention, severity of adverse events reported, and participant experiences.
  2. To measure key outcome variables, including completion rates, missing data, estimates, variances, and 95% confidence intervals for between-group differences.

The study is designed as a randomized controlled pilot trial. Eligible participants will be randomized to either the intervention group (HIFE+cog) or the active control group (HIFE) to partake in individually tailored exercise, supervised and progressed by a physiotherapist, two times per week for 3 months.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Umeå, Sweden, 90187
        • Recruiting
        • Umeå University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • aged 75 years or older
  • moderate risk of falling (feeling unsteady or afraid of falling, or having fallen in the past year, with a self-selected gait speed ≤0,8 m/s or TUG >15 s without walking aid)
  • can walk independently indoors, without a walking aid
  • can walk 500m independently outdoors, with or without a walking aid

Exclusion Criteria:

  • a high fall risk (≥2 falls in the past year, serious injury e.g. hip fracture from a fall in the past year requiring medical care, or inability to get up from the floor after a fall)
  • Mini-Mental State Examination (MMSE) score <24 or dementia diagnosis
  • a medical condition that may affect participation in high-intensity gait, balance, and leg strength exercise, or other movement-related conditions affecting exercise or tests (e.g., pain, dizziness, visual or hearing impairment)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-intensity functional exercise with cognitive challenge (HIFE+Cog)
High intensity functional exercise (HIFE+Cog) program with simultaneous cognitive challenge, individually tailored and performed twice weekly for 12 weeks, in supervised groups.
Each session will consist of individually tailored exercises performed at weight- bearing positions and covering lower leg strengthening exercises, as well as static- and dynamic balance exercises. Simultaneous cognitive exercises are added to static and dynamic balance exercises. Relative exercise intensity is encouraged to be moderate to high, and progressively adjusted by for example altering load or difficulty of the exercise. Session duration is 1 hour, including warm-up.
Active Comparator: High-intensity functional exercise (HIFE)
High intensity functional exercise (HIFE) program, individually tailored and performed twice weekly for 12 weeks, in supervised groups.
Each session will consist of individually tailored exercises performed at weight- bearing positions and covering lower leg strengthening exercises, as well as static- and dynamic balance exercises. Relative exercises intensity is encouraged to be moderate to high, and progressively adjusted by for example altering load or difficulty of the exercise. Session duration is 1 hour, including warm-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment
Time Frame: Before intervention start
Rate of recruited participants, and sources for recruitment
Before intervention start
Adherence
Time Frame: Through the 3-month intervention
Number of exercise sessions attended
Through the 3-month intervention
Exercise intervention content and delivery
Time Frame: Through the 3-month intervention
Number of exercises, sets, repetitions, and intensity achieved measured using a standardized exercise diary completed by supervisors after each session
Through the 3-month intervention
Retention
Time Frame: Through the 3-month intervention
Number of participants that completed follow-ups
Through the 3-month intervention
Safety
Time Frame: Through the 3-month intervention period
Adverse events, including falls and discomfort reported during or between sessions by participants or supervisors, and measured using a standardized exercise diary completed by supervisors after each session
Through the 3-month intervention period
Balance and gait capacity
Time Frame: Baseline, 3 months
The Timed up and go (TUG) test, with and without cognitive task
Baseline, 3 months
Balance and gait capacity
Time Frame: Baseline, 3 months
The 4m forward gait speed test, with and without cognitive task
Baseline, 3 months
Balance and gait capacity
Time Frame: Baseline, 3 months
The 4m backward gait speed test
Baseline, 3 months
Balance and gait capacity
Time Frame: Baseline, 3 months
The Berg balance scale
Baseline, 3 months
Balance and gait capacity
Time Frame: Baseline, 3 months
The 30-s Chair stand test
Baseline, 3 months
Cognitive function
Time Frame: Baseline, 3 months
The Mindmore cognitive battery: Mental speed with The Symbol-Digit Processing test
Baseline, 3 months
Cognitive function
Time Frame: Baseline, 3 months
The Mindmore cognitive battery: Mental speed with The Reaction test I and II
Baseline, 3 months
Cognitive function
Time Frame: Baseline, 3 months
The Mindmore cognitive battery: Attention and executive function (shifting) with The Trail making test - Click (TMT-Click)
Baseline, 3 months
Cognitive function
Time Frame: Baseline, 3 months
The Mindmore cognitive battery: Short term- and working memory with The Corsi Block test
Baseline, 3 months
Cognitive function
Time Frame: Baseline, 3 months
The Mindmore cognitive battery: Executive function (inhibition) with The Stroop test
Baseline, 3 months
Cognitive function
Time Frame: Baseline, 3 months
The Mindmore cognitive battery: Executive function (verbal fluency) with The FAS test
Baseline, 3 months
Occupational performance
Time Frame: Baseline, 3 months
The Canadian Occupational Performance Measure (COPM)
Baseline, 3 months
Experiences of the intervention and effects
Time Frame: 3 months
Individual interviews with participants in the intervention group
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fear of falling
Time Frame: Baseline, 3 months
The Falls Self-Efficacy Scale (FES-I)
Baseline, 3 months
Psychological wellbeing
Time Frame: Baseline, 3 months
The Philadelphia Geriatric Center Morale Scale (PGCMS)
Baseline, 3 months
Physical activity
Time Frame: Baseline, 3 months
The International Physical Activity Questionnaire-Elderly (IPAQ-E)
Baseline, 3 months
Depressive disorders
Time Frame: Baseline, 3 months
The Geriatric Depression Scale (GDS-15)
Baseline, 3 months
Health related quality of life
Time Frame: Baseline, 3 months
The EQ5D, Selected questions from The short form (36) Health survey
Baseline, 3 months
Activities of daily life (ADL)
Time Frame: Baseline, 3 months
The Katz ADL Index
Baseline, 3 months
Descriptive information
Time Frame: Baseline
Age, gender, education, living conditions, past and current medical conditions and medications from self-reported questionnaire
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Annika Toots, PhD, Umeå University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2025

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

January 7, 2025

First Submitted That Met QC Criteria

January 11, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 21, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Dnr 2024-07683-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The datasets generated and analysed during the study will not publicly available to protect the participants' confidentiality (in accordance with The General Data Protection Regulation, European Union Regulation) but are available from the principal investigator on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gait

Clinical Trials on HIFE+cog

Subscribe